Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Raffeld

Showing results (161-170 of 276) with videos related to

Pageof 28
Sort By:
Blood|May 20, 2006
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphomaLeticia Quintanilla-Martinez, Stefania Pittaluga, Cornelius Miething, et al.
The American Journal of Surgical Pathology|January 4, 2023
Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic AnalysisIfeyinwa E Obiorah, Jeremiah Karrs, Laura Brown, et al.
The Lancet. Oncology|November 5, 2020
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid glandSriram Gubbi, Shilpa Thakur, Shirisha Avadhanula, et al.
Acta Neuropathologica|October 18, 2024
MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genesHye-Jung Chung, Sharika Rajan, Zhichao Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersWyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.
Cancer Research|March 13, 2002
Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarraysSpyro Mousses, Lukas Bubendorf, Urs Wagner, et al.
Blood|November 17, 2010
Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasisJulie E Niemela, Lianghao Lu, Thomas A Fleisher, et al.
The American Journal of Surgical Pathology|September 27, 2007
IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolutionZhengrong Mao, Leticia Quintanilla-Martinez, Mark Raffeld, et al.
The American Journal of Surgical Pathology|June 30, 2018
Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency SettingsShunyou Gong, Genevieve M Crane, Chad M McCall, et al.
Pageof 28

Showing results (161-170 of 276) with videos related to

Sort By:
Pageof 28
Blood|May 20, 2006
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphomaLeticia Quintanilla-Martinez, Stefania Pittaluga, Cornelius Miething, et al.
The American Journal of Surgical Pathology|January 4, 2023
Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic AnalysisIfeyinwa E Obiorah, Jeremiah Karrs, Laura Brown, et al.
The Lancet. Oncology|November 5, 2020
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid glandSriram Gubbi, Shilpa Thakur, Shirisha Avadhanula, et al.
Acta Neuropathologica|October 18, 2024
MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genesHye-Jung Chung, Sharika Rajan, Zhichao Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersWyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.
Cancer Research|March 13, 2002
Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarraysSpyro Mousses, Lukas Bubendorf, Urs Wagner, et al.
Blood|November 17, 2010
Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasisJulie E Niemela, Lianghao Lu, Thomas A Fleisher, et al.
The American Journal of Surgical Pathology|September 27, 2007
IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolutionZhengrong Mao, Leticia Quintanilla-Martinez, Mark Raffeld, et al.
The American Journal of Surgical Pathology|June 30, 2018
Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency SettingsShunyou Gong, Genevieve M Crane, Chad M McCall, et al.
Pageof 28